These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6610355)

  • 1. Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed pneumococcus-Staphylococcus aureus pneumonia.
    Drelichman V; Cushing RD; Bawdon RE; Lerner AM
    Am J Med Sci; 1984; 287(3):39-43. PubMed ID: 6610355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of penicillin-resistant pneumococcus with penicillin: a case report.
    Spencer J; Gonzalez L; Miller RP; Myers ML
    J Fam Pract; 1997 May; 44(5):499-503. PubMed ID: 9152269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of the susceptibility to penicillin G of Streptococcus pneumoniae at the Limoge University Hospital Center].
    Ploy MC; Beaudouin CM; Mounier M; Denis F
    Pathol Biol (Paris); 1995 Apr; 43(4):241-4. PubMed ID: 7567108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin-insensitive pneumococcus: a case report from South Carolina.
    Howell RR; Bendt P
    J S C Med Assoc; 1986 Aug; 82(8):507-8. PubMed ID: 3463830
    [No Abstract]   [Full Text] [Related]  

  • 5. Penicillin-insensitive pneumococci: isolation from patients with pneumonia.
    Perlino CA; Burleigh P
    South Med J; 1979 Jan; 72(1):20-2. PubMed ID: 32628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Various prospective approaches to the treatment of nonspecific lung diseases].
    Sil'vestrov VP; Vanina NF
    Ter Arkh; 1980; 52(3):3-12. PubMed ID: 6966837
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental mouse models of susceptible and resistant pneumococcal pneumonia with special reference to the cause of bacteremia].
    Tamada S
    Kansenshogaku Zasshi; 1998 Nov; 72(11):1225-31. PubMed ID: 9884510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A child with pneumonia caused by a multiresistant pneumococcus].
    Verhoef-Verhage EA; Fleer A
    Ned Tijdschr Geneeskd; 1990 Apr; 134(15):770-2. PubMed ID: 2336115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of high-dose penicillin G for pneumococcal pneumonia diagnosed based on initial comprehensive assessment at admission: an observational study.
    Komagamine J
    BMC Res Notes; 2018 Jun; 11(1):399. PubMed ID: 29925417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Bacteriological findings in pneumonia.
    Kinnell H
    Lancet; 1974 Feb; 1(7850):222. PubMed ID: 4129913
    [No Abstract]   [Full Text] [Related]  

  • 12. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.
    Pallares R; Gudiol F; Liñares J; Ariza J; Rufi G; Murgui L; Dorca J; Viladrich PF
    N Engl J Med; 1987 Jul; 317(1):18-22. PubMed ID: 3587309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia.
    Waterer GW; Jennings SG; Wunderink RG
    Chest; 1999 Nov; 116(5):1278-81. PubMed ID: 10559087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
    Poirier R
    Presse Med; 1998 Sep; 27 Suppl 4():14-5. PubMed ID: 9798478
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of pneumococcal pneumonia: the case for penicillin G.
    Bryan CS
    Am J Med; 1999 Jul; 107(1A):63S-68S. PubMed ID: 10451011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods.
    Low DE
    Infect Dis Clin North Am; 1998 Sep; 12(3):613-30, viii. PubMed ID: 9779381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningitis from a pneumococcus moderately resistant to penicillin.
    Gartner JC; Michaels RH
    JAMA; 1979 Apr; 241(16):1707-9. PubMed ID: 34736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.